{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:34:35Z","timestamp":1760852075174,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jsbmb.2004.03.104","type":"journal-article","created":{"date-parts":[[2004,5,13]],"date-time":"2004-05-13T09:44:36Z","timestamp":1084441476000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1\u03b1,25-dihydroxyvitamin D3"],"prefix":"10.1016","volume":"89-90","author":[{"given":"Hector F.","family":"DeLuca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2004.03.104_BIB1","unstructured":"H.F. DeLuca, Historical overview, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 1, pp. 3\u201311."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of Vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1523-1755.63.s85.20.x","article-title":"New Vitamin D analogs","volume":"85","author":"Slatopolsky","year":"2003","journal-title":"Kidney Int. Suppl."},{"issue":"3","key":"10.1016\/j.jsbmb.2004.03.104_BIB4","first-page":"888","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses PTH secretion in uremic rats in the absence of hypercalcemia","volume":"5","author":"Slatopolsky","year":"1994","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ajkd.2001.22077","article-title":"Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2) in dialysis patients with secondary hyperparathyroidism: a sequential comparison","volume":"37","author":"Maung","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.jbchem.a124346","article-title":"The binding properties, with blood proteins, and tissue distribution of 22-oxa-1\u03b2,25-dihydroxyvitamin D3, a noncalcemic analogue of 1\u03b2,25-dihydroxyvitamin D3, in rats","volume":"115","author":"Kobayashi","year":"1994","journal-title":"J. Biochem."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB7","first-page":"1143","article-title":"Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1\u03b2,25-dihydroxyvitamin D3 and synthetic analogues of Vitamin D3 with an oxygen atom in the side chain","volume":"19","author":"Morimoto","year":"1989","journal-title":"Biochem. Int."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3177\/jnsv.36.21","article-title":"Prevention of immunological disorders in MRL\/1 mice by a new synthetic analogue of Vitamin D3: 22-oxa-1\u03b2,25-dihydroxyvitamin D3","volume":"36","author":"Abe","year":"1990","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB9","first-page":"147","article-title":"Efficacy of topical treatment in psoriasis with MC 903, a new Vitamin D analogue","volume":"69","author":"Stabert","year":"1989","journal-title":"Acta Derm. Venereol. (Stockh.)"},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB10","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1016\/S0040-4020(01)86903-9","article-title":"Synthesis of MC 904, a biologically active Vitamin D metabolite","volume":"43","author":"Calverley","year":"1987","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB11","first-page":"401","article-title":"Origin of the use of calcipotriol in psoriasis treatment","volume":"3","author":"Binderup","year":"1992","journal-title":"Rev. Contemp. Pharmacother."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB12","unstructured":"A.J. Brown, E. Slatopolsky, Mechanisms for the selective actions of Vitamin D analogs, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 59, pp. 995\u20131009."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB13","unstructured":"G. Jones, Analog metabolism, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 58, pp. 973\u2013994."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0040-4039(00)98795-1","article-title":"1\u03b2,25-Dihydroxy-19-nor-vitamin D3, a novel Vitamin D-related compound with potential therapeutic activity","volume":"31","author":"Perlman","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB15","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1021\/jm9802618","article-title":"New 1\u03b2,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl and 2-methylene analogs","volume":"41","author":"Sicinski","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB16","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1021\/jm020007m","article-title":"2-Ethyl and 2-ethylidene analogues of 1\u03b2,25-dihydroxy-19-norvitamin D3: synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain","volume":"45","author":"Sicinski","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB17","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1073\/pnas.202471299","article-title":"a novel potent analog of 1\u03b2,25-dihydroxyvitamin D3 selectively induces bone formation","volume":"99","author":"Shevde","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcb.10331","article-title":"Vitamin D and bone","volume":"88","author":"Suda","year":"2003","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB19","unstructured":"T. Suda, N. Takahashi, Vitamin D and osteoclastogenesis, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D, Academic Press, San Diego, 1997, Chapter 21, pp. 329\u2013340."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB20","unstructured":"L. Plum, X. Ma, M. Clagett-Dame, N. Shevde, L. Fitzpatrick, J.W. Pike, H.F. DeLuca, 2-Methyelene-19-nor-(20S)-1,25-dihydroxyvitamin D3 (2MD), an analog of 1\u03b2,25-dihydroxyvitamin D3 (VD) markedly increases bone mass of ovariectomized (OVX) rats, ASBMR (2002) (Abstract)."},{"key":"10.1016\/j.jsbmb.2004.03.104_BIB21","doi-asserted-by":"crossref","unstructured":"H. Yamamoto, N.K. Shevde, A. Warrier, L.A. Plum, H.F. DeLuca, J.W. Pike, 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the Vitamin D receptor in osteoblasts, J. Biol. Chem. 278 (2003) 31756\u201331765.","DOI":"10.1074\/jbc.M304737200"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004001050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004001050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:53:36Z","timestamp":1760734416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076004001050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":21,"alternative-id":["S0960076004001050"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2004.03.104","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1\u03b1,25-dihydroxyvitamin D3","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2004.03.104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}